[1] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[2] |
SU Xin, FAN Wenyi, XU Xinye, XU Xuedong.
Analysis of risk factors and attributable disease burden of four major chronic diseases including cancer in the Chinese population
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 442-447.
|
[3] |
ZHANG Tianyang, XIAO Wen, XIN Zhenjiang, XIE Junqing.
Analysis of screening results of early diagnosis and treatment program for colorectal cancer in rural areas Fengtai district,Beijing,2015—2022
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 447-453.
|
[4] |
LI Shuimei, XU Sujuan, YIN Hai, ZHONG Yanmei, LIU Yingying, LIANG Jingyan.
Machine learning-based analysis of risk factors for postoperative facial paralysis in patients with parotid tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 481-486.
|
[5] |
LI Wei, LIU Ligang, YANG Junquan, LIU Chun, ZHANG Zhixue, GAO Fuchun, ZHANG Caixia, LIU Shuhong, LI Xinyu.
Analysis of the risk factors of anastomotic leakage after total laparoscopic transrectal specimen extraction surgery (NOSES Ⅳ) for colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 564-569.
|
[6] |
ZHAN Shicheng, CHEN Peiqin, QIU Moqin, WEN Qiuping, ZHOU Zihan, LIN Qiuling, JIANG Yanji, ZHOU Xianguo, CAO Ji, GUO Qian, NONG Cunli, YU Hongping, LIU Yingchun.
Association of genetic variants in eukaryotic translation initiation factor 3 and risk of HBV⁃related hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 62-69.
|
[7] |
MA Xiaohua, WU Kunjin, HUANG Qichao, QU Kai, MA Lei.
The value of peripheral blood GPC3 in the clinical diagnosis of hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(1): 38-44.
|
[8] |
LEI Ruijiao, ZHANG Meizhen, WANG Le, FANG Zhimei, WANG Youqing, LI Huizhang, ZHU Chen, DU Lingbin.
Analysis of screening results of urban cancer early diagnosis and treatment program in Quzhou city,Zhejiang province ,2014—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 618-623.
|
[9] |
ZHU Zhanhui, CAO Ji, YU Jiahua, LI Qiulin, YANG Ziyi, GE Lianying, RONG Minhua.
Assessment of cancer risk and analysis of screening results of cancer screening program in urban Guangxi from 2014 to 2017
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(6): 681-685.
|
[10] |
QIN Siyuan, LI Chenghao.
Association between PSCA gene rs2976392 polymorphism and susceptibility of gastric cancer in Chinese population:a meta-analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 457-462.
|
[11] |
WANG Liang, ZHOU Xuan, LIANG Xiaojie, HE Yingzhi.
A novel six-gene based prognostic model for patients with diffuse large B-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(3): 328-334.
|
[12] |
JIANG Zhou, HUANG Haixin, CHEN Dagui, YANG Hui, WU Sibei, XU Zhuohua, LU Ying.
Risk factors of vertebral artery stenosis after intensity-modulated radiation therapy for nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(3): 347-351.
|
[13] |
LIU Jinlu, QIN Xingan, LI Changhua, LUO Yihuan, CHEN Junqiang.
Risk factors and prognostic analysis of lymph node metastasis in No.14v group in gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 69-74.
|
[14] |
WU Yuanyuan, WANG Jun, MAO Aihong, FAN Xiangda, ZHANG Jianwei, DUAN Ying.
Establishment and verification of a scoring system for predicting central lymph node metastasis in papillary thyroid carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 498-502.
|
[15] |
PENG Ning, TAO Yiwen, HENG Songqing, YANG Hong, SHANG Liming, XIAO Kaiyin.
Ultrasound guided fusion virtual CT navigation radiofrequency therapy for high risk sites of primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 412-415.
|